Mumbai, India

Triptikumar Mukhopadhyay


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Triptikumar Mukhopadhyay

Introduction

Triptikumar Mukhopadhyay is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of renal disorders and rheumatic diseases. With a total of three patents to his name, Mukhopadhyay's work reflects a commitment to advancing medical science.

Latest Patents

One of his latest patents is focused on a herbal extract for renal disorders. This invention relates to the use of a standardized extract as an immunoadjuvant in treating conditions such as nephrotic syndrome and chronic recurrent urinary tract infections. The invention also includes pharmaceutical compositions that utilize this extract and methods for treating these renal disorders. Another significant patent involves crystalline glucosamine sulfate metal salts. This invention pertains to novel crystalline glucosamine sulfate metal salts designed for treating acute and chronic forms of rheumatic and arthritic diseases. The salts have low metal content, specifically sodium or potassium, and the patent outlines a solution-based and solvent-free process for their preparation.

Career Highlights

Throughout his career, Mukhopadhyay has worked with prominent companies such as Nicholas Piramal India Limited and Aventis Pharma Deutschland, GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Ravi Gajanan Bhat and E S Sreekumar, who have collaborated with him on various projects.

Conclusion

Triptikumar Mukhopadhyay's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to impact the treatment of renal and rheumatic disorders significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…